Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
about
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis opticaSystemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease.Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model.White matter astrocytes in health and disease.Regulation of gap junction channels by infectious agents and inflammation in the CNS.Microglia of prefrontal white matter in suicideEarly disruption of glial communication via connexin gap junction in multiple sclerosis, Baló's disease and neuromyelitis optica.Adipocytes in both brown and white adipose tissue of adult mice are functionally connected via gap junctions: implications for Chagas disease.Activated immune response in an inherited leukodystrophy disease caused by the loss of oligodendrocyte gap junctions.Connexins-mediated glia networking impacts myelination and remyelination in the central nervous system.Mechanisms of white matter damage in multiple sclerosis.Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.Oligodendroglia: metabolic supporters of neurons.Endogenous repair and development inspired therapy of neurodegeneration in progressive multiple sclerosis.Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis.Connexins and their channels in inflammation.Connexins and pannexins: At the junction of neuro-glial homeostasis & disease.Mouse Hepatitis Virus Infection Remodels Connexin43-Mediated Gap Junction Intercellular Communication In Vitro and In Vivo.Microtubule-assisted altered trafficking of astrocytic gap junction protein connexin 43 is associated with depletion of connexin 47 during mouse hepatitis virus infection.Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model.Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitis.Remyelinating Pharmacotherapies in Multiple Sclerosis.A Unique TGFB1-Driven Genomic Program Links Astrocytosis, Low-Grade Inflammation and Partial Demyelination in Spinal Cord Periplaques from Progressive Multiple Sclerosis Patients.Function of Connexins in the Interaction between Glial and Vascular Cells in the Central Nervous System and Related Neurological Diseases.Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesionsConnexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia
P2860
Q21132530-F92A36AD-DF63-4F49-BB24-1300D6DE3BFDQ27316720-CFBDD28D-96B4-4CEE-A6C4-098B2EE0DE72Q33592396-3A8719B1-541C-4E19-9402-1499626AF170Q33594651-7F44F117-5AFD-410B-A4DB-ACDECE918E1AQ33620254-A8B21636-D484-4625-AB4B-BBACDB5B8DEAQ34076322-ACB8E7EF-041E-4C60-B355-F6A76DE4B1E3Q34478062-2C4EAEA8-F3C7-40B9-BEB9-4A6CEC1D75B1Q35160062-3C4D376F-C1C3-4414-9E15-07E06F466A0FQ36269130-FEDCB3FE-A057-4C1D-B1CF-A5D19D591337Q38176244-0B2DF6B4-E629-4337-8FA9-AB9D6F9A9191Q38182524-E38AAEA7-9A1C-4FB1-8BEC-39367DD10693Q38333532-17527796-634D-4B1F-AEBB-6EB947554F72Q38598063-42CA7E7B-E06D-4148-B8AD-F37A52E2C7C6Q38765008-AFE52113-D9DD-4632-B3B1-BA37EB764371Q38859739-608D59B8-96F0-463B-A176-3689EEB19651Q38888995-A77F27D8-12BE-44A7-86D0-9589B98F0B52Q39350483-5DF6717D-F0D2-4A01-A92D-82A680E7FE7FQ39604585-ADC648BE-F395-4F3B-ABAA-84C506899330Q40178608-90A27473-4A59-497D-94F7-A0E931C31AF1Q40374604-60DB329A-6F05-41C3-B918-5FCCEF330118Q41011933-2AC332BF-1AE5-468C-AE15-E002DE453B88Q46682011-B86A1044-B911-4C7A-9A86-4C06432538F6Q46989452-95FEA827-1F5D-4218-870A-D8B3A1BE0A91Q55455023-0180E91D-D81F-4668-8435-DE2ED468B99FQ57562078-493C2400-1AE0-4627-A9D4-6D116E2A352EQ59134975-C75BB82D-471A-4D41-A402-2466BBE1E431
P2860
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
@en
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
@nl
type
label
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
@en
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
@nl
prefLabel
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
@en
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
@nl
P2093
P2860
P1476
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
@en
P2093
Andreas Hadjisavvas
Federico Roncaroli
Irene Sargiannidou
Kleopas A Kleopa
Kyriaki Markoullis
Natasa Schiza
Richard Reynolds
P2860
P2888
P304
P356
10.1007/S00401-012-0978-4
P577
2012-04-07T00:00:00Z